★
Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads: coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

Guided View
New to markets (prices, yields, YTD, market cap)? We explain every term as you browse, in plain English. Same data, with the help built in.

Expert View
You already know the market. Just the data: clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Security record · archived quarter

AVTX

Avalo Therapeutics, Inc. · Healthcare · Biotechnology

12.36 +6.6% mkt cap $662.87M quote delayed (FMP) · as of Oct 20 22:08 UTC · separate from filing data below

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024
38Tracked holders
+3Δ holders
12.35MShares held
$184.22MReported value
+7New positions
−4Exits
Strongly Rising Conviction score 71/100 4 quarters of rising tracked shares ●●●●○○ How these are computed → Explain this at the Research Desk →

Momentum inputs (comparable managers): holder breadth +8.6% · share flow +30.0% · net new positions +7.9% · formula
Broad accumulation: rising shares across more holders

All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2026

Ownership over time
QuarterHoldersΔSharesReported valueNewExits
Q2 2026 51 +13 31.74M $586.58M +19 −6
Q1 2026 38 +3 12.35M $184.22M +7 −4
Q4 2025 35 +2 8.20M $148.88M +2 n/a
Q3 2025 13 +7 3.14M $39.85M +7 n/a
Q2 2025 4 +1 446.19K $2.23M +1 n/a
Q1 2025 1 -1 107.81K $864,389 n/a −1
Q4 2024 2 +1 120.18K $892,907 +1 n/a
Q3 2024 1 +1 10.11K $95,649 +1 n/a
Holder count
Who holds it · Q1 2026
#ManagerSharesΔ sharesValueTheir weightHeld
1 Fidelity (FMR) ✦ 2.88M +1207.1% $42.99M 0.0% ▲ Add 2 SEC ↗ ×3
2 UBS Group AG 1.14M +139.0% $17.05M 0.0% ▲ Add 2 SEC ↗ ×2
3 Point72 Asset Management ✦ 916.14K +46.0% $13.68M 0.0% ▲ Add 3 SEC ↗
4 Adage Capital Partners ✦ 854.00K +55.3% $12.75M 0.0% ▲ Add 3 SEC ↗
5 Millennium Management ✦ 835.48K +26.6% $12.47M 0.0% ▲ Add 3 SEC ↗
6 Balyasny Asset Management L.P. 731.59K +66.5% $10.92M 0.0% ▲ Add 2 SEC ↗
7 Vanguard Capital Management Llc 719.69K n/a $10.75M 0.0% n/c 1 SEC ↗
8 Bank Of America Corp /De/ 643.00K +3.5% $9.60M 0.0% ▲ Add 2 SEC ↗ ×2
9 Jennison Associates Llc 470.77K -1.0% $7.03M 0.0% ▼ Trim 2 SEC ↗
10 Bnp Paribas Financial Markets 422.78K +113.8% $6.31M 0.0% ▲ Add 2 SEC ↗
11 BlackRock ✦ (passive) 327.08K +12.9% $4.88M 0.0% ▲ Add 4 SEC ↗ ×7
12 Citadel Advisors ✦ 193.74K -53.8% $2.89M 0.0% ▼ Trim 3 SEC ↗ ×2
13 JPMorgan Chase ✦ 194.39K +337.5% $2.71M 0.0% ▲ Add 3 SEC ↗ ×2
14 Qube Research & Technologies Ltd 174.51K +170.7% $2.61M 0.0% ▲ Add 2 SEC ↗
15 Jane Street Group, Llc 173.32K -3.1% $2.59M 0.0% ▼ Trim 2 SEC ↗ ×3
16 Ameriprise Financial Inc 172.15K -21.0% $2.57M 0.0% ▼ Trim 2 SEC ↗
17 Aberdeen Group plc 171.68K +79.9% $2.56M 0.0% ▲ Add 2 SEC ↗
18 Geode Capital Management ✦ (passive) 169.89K +2.2% $2.54M 0.0% ▲ Add 7 SEC ↗ ×2
19 Morgan Stanley ✦ 161.39K -39.1% $2.41M 0.0% ▼ Trim 3 SEC ↗ ×4
20 Deutsche Bank Ag\ 150.00K 0.0% $2.24M 0.0% Held 2 SEC ↗
21 Marshall Wace ✦ 129.14K -74.6% $1.93M 0.0% ▼ Trim 3 SEC ↗ ×2
22 Renaissance Technologies ✦ 120.11K +556.4% $1.79M 0.0% ▲ Add 3 SEC ↗
23 Squarepoint Ops LLC 81.28K +99.0% $1.21M 0.0% ▲ Add 2 SEC ↗
24 State Street Global Advisors ✦ (passive) 71.65K -9.6% $1.07M 0.0% ▼ Trim 3 SEC ↗
25 Two Sigma Investments ✦ 64.42K -56.5% $961,865 0.0% ▼ Trim 4 SEC ↗
26 Goldman Sachs Group ✦ 60.11K -8.0% $897,383 0.0% ▼ Trim 2 SEC ↗
27 Sei Investments Co 56.85K New $848,830 0.0% New 1 SEC ↗
28 Td Asset Management Inc 51.41K New $767,521 0.0% New 1 SEC ↗
29 Hrt Financial Lp 48.10K New $718,000 0.0% New 1 SEC ↗
30 Man Group plc 46.55K New $695,036 0.0% New 1 SEC ↗
31 Dimensional Fund Advisors Lp 40.82K New $607,287 0.0% New 1 SEC ↗ ×4
32 Northern Trust Corp 30.56K -5.1% $456,201 0.0% ▼ Trim 2 SEC ↗
33 Envestnet Asset Management Inc 20.00K +24.7% $298,540 0.0% ▲ Add 2 SEC ↗
34 Barclays Plc 14.64K -86.2% $218,605 0.0% ▼ Trim 2 SEC ↗ ×3
35 Charles Schwab Investment… 10.00K New $149,300 0.0% New 1 SEC ↗
36 Us Bancorp \De\ 3.39K +23.9% $50,568 0.0% ▲ Add 2 SEC ↗ ×2
37 Royal Bank Of Canada 216 New $2,000 0.0% New 1 SEC ↗ ×3
38 Osaic Holdings, Inc. 1 0.0% $14 0.0% Held 2 SEC ↗

“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.

New buyers

Sei Investments Co $848,830 0.0%
Td Asset Management Inc $767,521 0.0%
Hrt Financial Lp $718,000 0.0%
Man Group plc $695,036 0.0%
Dimensional Fund Advisors Lp $607,287 0.0%
Charles Schwab Investment… $149,300 0.0%
Royal Bank Of Canada $2,000 0.0%

Exited

Susquehanna International… $3.83M was 0.0%
Belvedere Trading LLC $82,192 was 0.0%
Citigroup Inc $20,757 was 0.0%
Group One Trading Llc $18 was 0.0%

Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 96 holders, 30.91M shares, $428.51M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.

Frequently co-owned

What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.

Insider transactions

Open-market purchases (P)

No open-market insider purchases in our coverage window.

Open-market sales (S)

Sep 16 Sullivan Christopher Ryan

Officer · 12.39K sh · $202,437

Sep 10 Sullivan Christopher Ryan

Officer · 10.19K sh · $179,457

Aug 28 Doyle Mittie

Officer · 679 sh · $13,580

Aug 18 Sullivan Christopher Ryan

Officer · 31.03K sh · $622,324

Aug 17 Sullivan Christopher Ryan

Officer · 37.95K sh · $753,333

Aug 17 Sullivan Christopher Ryan

Officer · 3.75K sh · $74,762

Aug 17 Doyle Mittie

Officer · 1.00K sh · $20,000

Aug 11 Riley Jennifer

Officer · 2.65K sh · $52,012

Aug 10 Doyle Mittie

Officer · 679 sh · $13,580

Awards, exercises and tax withholding are never counted as buys or sales here. Methodology

Beneficial ownership
Aug 14 SC 13G/A: T. Rowe Price Investment Management…

View original SEC filing ↗

Aug 14 SC 13G/A: Caligan Partners LP

View original SEC filing ↗

Aug 14 SC 13G/A: RA CAPITAL MANAGEMENT, L.P.

View original SEC filing ↗

Aug 14 SC 13G/A: Deep Track Capital, LP

View original SEC filing ↗

Aug 14 SC 13G/A: Nantahala Capital Management, LLC

View original SEC filing ↗

Aug 14 SC 13G/A: BIOTECHNOLOGY VALUE FUND L P

View original SEC filing ↗

Aug 14 SC 13G/A: Avoro Capital Advisors LLC

View original SEC filing ↗

Aug 13 SC 13G/A: Affinity Asset Advisors, LLC

View original SEC filing ↗

Aug 07 SC 13G/A: FMR LLC

View original SEC filing ↗

Aug 07 SC 13G: STATE STREET CORP

View original SEC filing ↗

Aug 06 SC 13G/A: FMR LLC

View original SEC filing ↗

Jul 27 SC 13G: BlackRock, Inc.

View original SEC filing ↗

Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR. Reporting period: Q1 2026 · Methodology · Get this via the API